Clares, MP, Lodeiro C, Fernandez D, Parola AJ, Pina F, Garcia-Espana E, Soriano C, Tejero R.
2006.
Specific interaction of citrate with bis(fluorophoric) bibrachial lariat aza-crown in comparison with the other components of the Krebs cycle, 2006. Chemical Communications. :3824-3826.
AbstractAmong the Krebs cycle components, just citrate enhances the fluorescence of a new bi(brachial) lariat aza-crown containing appended naphthalene fluorophores.
Franco, IS, Mota LJ, Soares CM, de Sá-Nogueira I.
2006.
Functional Domains of the Bacillus subtilis Transcription Factor AraR and Identification of Amino Acids Important for Nucleoprotein Complex Assembly and Effector Binding. Journal of Bacteriology. 188:3024-3036.
AbstractThe Bacillus subtilis AraR transcription factor represses at least 13 genes required for the extracellular degradation of arabinose-containing polysaccharides, transport of arabinose, arabinose oligomers, xylose, and galactose, intracellular degradation of arabinose oligomers, and further catabolism of this sugar. AraR exhibits a chimeric organization comprising a small N-terminal DNA-binding domain that contains a winged helix-turn-helix motif similar to that seen with the GntR family and a larger C-terminal domain homologous to that of the LacI/GalR family. Here, a model for AraR was derived based on the known crystal structures of the FadR and PurR regulators from Escherichia coli. We have used random mutagenesis, deletion, and construction of chimeric LexA-AraR fusion proteins to map the functional domains of AraR required for DNA binding, dimerization, and effector binding. Moreover, predictions for the functional role of specific residues were tested by site-directed mutagenesis. In vivo analysis identified particular amino acids required for dimer assembly, formation of the nucleoprotein complex, and composition of the sugar-binding cleft. This work presents a structural framework for the function of AraR and provides insight into the mechanistic mode of action of this modular repressor.
Trincao, J, Silva MS, Barata L, Bonifacio C, Carvalho S, Tomas AM, Ferreira AEN, Cordeiro C, Freire AP, Romao MJ.
2006.
Purification, crystallization and preliminary X-ray diffraction analysis of the glyoxalase II from Leishmania infantum. Acta Crystallographica Section F-Structural Biology and Crystallization Communications. 62:805-807.
Abstractn/a
Najmudin, S, Guerreiro C, Carvalho AL, Prates JAM, Correia MAS, Alves VD, Ferreira LMA, Romao MJ, Gilbert HJ, Bolam DN, Fontes C.
2006.
Xyloglucan is recognized by carbohydrate-binding modules that interact with beta-glucan chains. Journal of Biological Chemistry. 281:8815-8828., Number 13
Abstractn/a
Fiedeler, U, Krings B.
2006.
{Naturalness and Neuronal Implants – Changes in the perception of human beings}. , Number 8501: University Library of Munich, Germany
AbstractWith our contribution we would like to refer to the debate on nanotechnology (NT) and its implications for the public discourse on the relationship of human beings and technologies. Within NT the convergence of some technologies has been considered as a crucial step towards the long term objective of “enhancing human performance”. The discussion was initiated with an US-American workshop in the year 2002, where the innovative character of converging technology (CT) was strongly underlined (Roco 2002). In the final document of the workshop futuristic and far reaching scenarios on technical development based on NT and on CT were presented. First we address the implications of the mentioned document for research policy in general and especially of NT. Based on the example of neural implants we second qualify the normative expectations within the debate without however denying the helpfulness of these innovations especially in the field of medicine. But we third agree on a critical discussion, which consider a new quality of technological penetration into social and human processes.